War in Ukraine Disrupts Trials, Cancer Care
Elie Dolgin • May 2, 2022
The war in Ukraine is disrupting routine patient care, clinical trials, and basic cancer research—with potentially dire consequences. Physicians and researchers are helping patients as best they can, but cancer mortality is expected to rise in the country, and the impact on research could slow medical progress.
Continue reading at Cancer Discovery.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.